Featured Research

from universities, journals, and other organizations

Academia should fulfill social contract by supporting bioscience startups, case study says

Date:
October 25, 2012
Source:
University of California - San Francisco
Summary:
Universities not only provide the ideal petri dish for cultivating bioscience with commercial potential, but have a moral obligation to do so, given the opportunity to translate public funding into health and jobs, according to a new case study.

Universities not only provide the ideal petri dish for cultivating bioscience with commercial potential, but have a moral obligation to do so, given the opportunity to translate public funding into health and jobs, according to a new case study by UCSF researchers.

In an analysis published October 24 in Science Translational Medicine, researchers at the California Institute for Quantitative Biosciences (QB3) assessed the impact of the institute's efforts over the past eight years in supporting entrepreneurs on the three UC campuses in which it operates: UCSF, UC Berkeley and UC Santa Cruz.

The study found that, by lowering the hurdle even very slightly for scientists to become entrepreneurs, the scientists were able to gain extraordinary traction in translating academic research into public benefit, generating 60 new companies in the first six years and attracting 75 new bioscience entrepreneurs in the last year alone.

"This fundamentally changes the way we think of academic science," said Douglas Crawford, PhD, assistant director of QB3 and senior author on the paper. "There is a distressing paucity of new drugs in the pipeline and a clear need for new economic engines in this country. This is a call to action to address that."

The paper cites the following essential support that universities can provide:

  • Bioscience-focused incubators
  • An open network approach that enables any entrepreneur to participate
  • Competitive seed funding options
  • Real-world mentoring that gives scientist a clear sense of market needs.

In the first six years since QB3 started supporting entrepreneurs at the UCSF Mission Bay campus, its growing network of incubators helped launch 60 new bioscience companies at UCSF and across the San Francisco Bay at UC Berkeley -- at a cost of $1 million per year. Of those, 56 are still in business, and 13 have moved beyond the incubator network or have been purchased by larger companies.

Together, those companies have created more than 280 jobs and attracted more than $230 million in either small business grants or venture capital funding for those companies, which are primarily focused on developing therapeutics, medical devices and research tools. That's a 38-fold return on investment, despite current negative trends in seed-stage investing, in addition to the public benefit of any products those companies generate.

The federal government invests $50 billion per year in academic research, including $23 billion for life sciences from the National Institutes of Health (NIH) alone, according to the paper. Both Baltimore, which is home to universities, and the San Francisco Bay Area receive about $2 billion annually in government research and development funding, yet productivity as measured by high-tech startups was 20-fold higher in the San Francisco area than Baltimore, the analysis found.

"This is clearly not an issue of how much funding is coming to the region. It's an issue of how we think about our social contract," said Regis B. Kelly, PhD, UCSF professor of biochemistry and biophysics, executive director of QB3 and a co-author on the paper. "Most people would say the public good a university offers is in providing research and education, but if we truly want to support the public with the benefits of science, we need to stop seeing economic growth and new medications as an inadvertent byproduct of academic research."

Many U.S. universities, including UCSF, are exploring ways to work with the private sector, with the multiple goals of invigorating research on campus, expediting drug development and ultimately improving the therapies that make it to the market.

That's a relatively new way of thinking, though, and one that often has been met with both skepticism and charges of conflicts of interest by those who believe science should be completely devoid of commercial influences.

"We have a fundamental charge as scientists to make an economic impact and to translate science into public benefit," Crawford said. "That's not a traditional way of thinking of universities, but at a certain point, we need to reassess that traditional thinking and take pride in the fact that a university's public contributions extends beyond its classrooms."

The paper points to the mission statement of the NIH, the nation's largest bioscience funding agency, which specifically includes a goal "to enhance the Nation's economic well-being and ensure a continued high return on the public investment in research."

"So as academic scientists, we are actually paid to protect and improve health, to prevent disease, and to enhance economic well-being," Crawford said. "This is not a sell-out to industry. It's an obligation to society."

Among the programs cited in the paper is a year-old mentoring program known as QB3 Startup in a Box, which connects scientists with external legal, professional and business experts to guide them in starting a new company. So far, the program has helped launch more than 75 virtual companies that are currently applying for grants, establishing business plans and pitching to investors. Seventeen are already operational.

Crawford emphasized that the goal of the analysis is not to assess blame, but to find solutions, and there are many. The authors also hope to generate discussion about which solutions work.

Co-authors include Kenneth D. Harrison, PhD and Neena S. Kadaba, PhD, also with QB3.

QB3 Startups By the Numbers

First Incubator or "Garage" at UCSF Mission Bay: 2006

Incubators Created: 5

Companies Started: 60

No. Currently in Garages: 45

No. Fledged and Thriving: 13

No. Jobs: 280

No. Virtual Companies (starting): 75

Funding Attracted: $230 million


Story Source:

The above story is based on materials provided by University of California - San Francisco. The original article was written by Kristen Bole. Note: Materials may be edited for content and length.


Journal Reference:

  1. K. D. Harrison, N. S. Kadaba, R. B. Kelly, D. Crawford. Building a Life Sciences Innovation Ecosystem. Science Translational Medicine, 2012; 4 (157): 157fs37 DOI: 10.1126/scitranslmed.3004487

Cite This Page:

University of California - San Francisco. "Academia should fulfill social contract by supporting bioscience startups, case study says." ScienceDaily. ScienceDaily, 25 October 2012. <www.sciencedaily.com/releases/2012/10/121025161755.htm>.
University of California - San Francisco. (2012, October 25). Academia should fulfill social contract by supporting bioscience startups, case study says. ScienceDaily. Retrieved September 19, 2014 from www.sciencedaily.com/releases/2012/10/121025161755.htm
University of California - San Francisco. "Academia should fulfill social contract by supporting bioscience startups, case study says." ScienceDaily. www.sciencedaily.com/releases/2012/10/121025161755.htm (accessed September 19, 2014).

Share This



More Science & Society News

Friday, September 19, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com
U.S. Food Makers Surpass Calorie-Cutting Pledge

U.S. Food Makers Surpass Calorie-Cutting Pledge

Newsy (Sep. 18, 2014) Sixteen large food and beverage companies in the United States that committed to cut calories in their products far surpassed their target. Video provided by Newsy
Powered by NewsLook.com
Stocks Hit All-Time High as Fed Holds Steady

Stocks Hit All-Time High as Fed Holds Steady

AP (Sep. 17, 2014) The Federal Reserve signaled Wednesday that it plans to keep a key interest rate at a record low because a broad range of U.S. economic measures remain subpar. Stocks hit an all-time high on the news. (Sept. 17) Video provided by AP
Powered by NewsLook.com
Some Tobacco Farmers Thrive Amid Challenges

Some Tobacco Farmers Thrive Amid Challenges

AP (Sep. 16, 2014) The South's tobacco country is surviving, and even thriving in some cases, as demand overseas keeps growers in the fields of one of America's oldest cash crops. (Sept. 16) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins